Carregant...
Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
AIM OF THE STUDY: Mutant NPM1 and CEBPA have been reported in patients with acute myeloid leukaemia (AML) and intermediate cytogenetic risk, and they appear to be associated with characteristic demographic and laboratory data, as well as clinical outcome. The objective of the study was to assess the...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Termedia Publishing House
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4171470/ https://ncbi.nlm.nih.gov/pubmed/25258581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2014.43490 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|